Eye Pharma Innovation challenge
Studies of glaucoma may involve the collection of aqueous humour (AH) from the eyes of patients, which involves the aspiration of a small volume of fluid from the anterior region of the eye through a fine aspiration needle.
Unfortunately, there are no commercial available medical devices specifically designed for AH sampling, which poses a challenge for the widespread dissemination and use of this pathology.
The initiative has the scope to identify possible partners with whom Eye Pharma could promote the design and commercialization of an optimized device for the collection of 50 µL of aqueous humour, by capillary sampling.
The aim is to select innovative players and start a collaboration agreement to integrate this innovative system into diagnostic technologies that could minimize the risk of infection and simplify the procedure for early diagnosis of the disease.
The initiative targets companies and startups, research centers, inventors with strong expertise on anterior chamber cannulae for aqueous humour sampling, syringes and medical devices for diagnostics.
The reason why
Timeline and stage of the process
3 months (November-January)
The call for applications is now open. You will have three months to submit your idea!
1 month (February)
By the end of February, we will evaluate the proposals with an audience of Key Opinion Leader of Glaucoma.
1 week (March)
We will select the potential winner of the call!
NDA and contract discussion
3 weeks (March)
Winner and collaboration activation
1 week (March)
We will activate the collaboration and start the project together!
End of April
We will present the project to an international event!
Contact us for info
if you have any questions or doubt, please reach out to email@example.com